Detalhe da pesquisa
1.
Thalidomide-dexamethasone versus interferon-alpha-dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study.
Br J Haematol
; 144(5): 653-9, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19036082
2.
Serum C-reactive protein at diagnosis and response to therapy is the most powerful factor predicting outcome of multiple myeloma treated with thalidomide/ anthracycline-based therapy.
Clin Lymphoma Myeloma
; 8(5): 294-9, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18854284
3.
Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.
Haematologica
; 91(1): 133-6, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16434383
4.
Comparison of two regimens for the treatment of elderly patients with acute lymphoblastic leukaemia (ALL).
Leuk Lymphoma
; 46(2): 233-8, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15621806
5.
Thalidomide plus oral melphalan compared with thalidomide alone for advanced multiple myeloma.
Hematol J
; 5(4): 312-7, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15297847
6.
High-dose daunorubicin as liposomal compound (Daunoxome) in elderly patients with acute lymphoblastic leukemia.
Hematol J
; 4(1): 47-53, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12692520
7.
Thalidomide plus oral melphalan for advanced multiple myeloma: a phase II study.
Haematologica
; 88(12): 1432-3, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14688003
8.
Thalidomide-dexamethasone plus pegylated liposomal doxorubicin vs. thalidomide-dexamethasone: a case-matched study in advanced multiple myeloma.
Eur J Haematol
; 78(4): 297-302, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17286608
9.
Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans.
Br J Haematol
; 136(5): 729-35, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17233770
10.
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma.
Blood
; 108(7): 2159-64, 2006 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16763209
11.
Risk assessment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates: a historical cohort study.
Cancer
; 101(3): 567-77, 2004 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15274070
12.
Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy.
Eur J Haematol
; 72(6): 403-9, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15128418